20
Fujian Kerui Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is CYCLOSPORINE, with a corresponding US DMF Number 13789.
Remarkably, this DMF maintains an Active status since its submission on September 01, 1998, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 16, 2014, and payment made on December 12, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II